<?xml version="1.0" encoding="UTF-8"?>
<p>Of the 26 participants that were positive for an STI, 26 have been treated (100%) following WHO STI treatment guidelines or were treated based on the STI test result in the absence of symptoms. All patients treated for NG in this cohort received ceftriaxone, in accordance with current national guidelines, and all who were symptomatic at the time of diagnosis experienced symptomatic improvement. Of the 26 who have been treated, 21 retested and 17 retested negative (81.0.0%) at 3–12 months posttreatment, 4 retested positive (16%) at 3–12 months posttreatment, 5 are due for retesting (20.0%).</p>
